Derm switched me back to fin from dut Finasteride/Dutasteride 7/29/2026
The user switched from finasteride to dutasteride, experienced continuous hair shedding, and was advised by a dermatologist to switch back to finasteride. The user plans to stick with finasteride and oral minoxidil, noting that dutasteride may cause prolonged shedding and potential side effects like gynecomastia.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Dutasteride Mesotherapy or Oral Finasteride
A user is considering dutasteride mesotherapy versus oral finasteride for hair loss, with concerns about side effects. Other users share experiences with both treatments, suggesting oral finasteride as more effective and cost-efficient, while also discussing the use of minoxidil, alfatradiol, and potential side effects like gynecomastia.
community 2 years or dutasteride and oral minoxidil results
Switching from finasteride to dutasteride and oral minoxidil led to thicker hair and reduced hairline recession. Occasional flushing from minoxidil will be managed by lowering the dose.
community Finasteride & Dutasteride success!
The user experienced hair loss and initially used Finasteride, but switched to Dutasteride after continued shedding. Dutasteride stabilized their hair density with mild side effects, and they did not use Minoxidil.
community Dermatologist refused to prescribe finasteride due to “new research” on male breast cancer. anyone heard of this?
A dermatologist refused to prescribe finasteride due to concerns about recent research linking it to male breast cancer, suggesting a topical alternative with minoxidil instead. The user is advised to seek a second opinion, as the evidence for such risks is inconclusive and the dermatologist's reasoning seems questionable.
community Has any premature balding guys actually saved and maintained their hair?
A user discusses their struggle with aggressive hair loss starting at a young age and their use of various treatments, including topical finasteride, minoxidil, dutasteride, and RU58841, without significant success. Other users share their experiences and suggest trying oral finasteride or dutasteride, topical spironolactone, and maintaining a vitamin regimen, while noting potential side effects like gynecomastia.
Related Research
6 / 6 resultsresearch Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología
This study involved a Delphi-method consensus from 34 Spanish dermatologists, outlining structured recommendations for managing androgenetic alopecia based on available scientific evidence and expert opinions, aiming to guide clinical practice amid limited treatment approvals and varying effectiveness.
research Cosmetic Approach for Men
This chapter reviews differences in dermatological treatments and conditions between male and female patients, particularly noting the impacts of sex steroids on various skin processes, but presents no new clinical findings.
research Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.
research Male androgenetic alopecia
This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
research Androgenetic Alopecia in Transgender and Gender Diverse Populations: A Review of Therapeutics
This review discusses treatment options for androgenetic alopecia in transgender and gender-diverse patients, highlighting first-line treatments like topical minoxidil and finasteride, but reports no new clinical results.
research The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms
This abstract outlines a guide reviewing both FDA-approved and off-label therapies for androgenetic alopecia and proposes treatment algorithms based on scientific research, highlighting a gap in common treatments for this prevalent condition.